Helikon Investments Raises Abivax Stake to 6.22%

• Helikon Investments held 6.22% of Abivax’s capital, representing 6.13% of voting rights, on October 8, 2026.
• The holding totaled 5,426,529 shares for its Helikon Long Short Equity Fund Master ICAV.
• Market purchases lifted its capital stake above 5% on September 24; voting rights crossed 5% on September 25.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.